Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Patient Blood Management Companies

ID: MRFR/HC/7326-HCR
112 Pages
Vikita Thakur
Last Updated: February 16, 2025
Patient Blood Management (PBM) is a holistic and patient-centered approach to managing and conserving blood resources, emphasizing the optimization of patient outcomes. Several companies have emerged as pioneers in the field of Patient Blood Management, playing a crucial role in transforming the healthcare landscape
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Patient Blood Management Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.27%
2024 Market Size$ 8.61 Billion
2025 Market Size$ 9.15 Billion
2035 Market Size$ 16.81 Billion
Key Players
Haemonetics
Terumo Corporation
Fresenius Kabi
Grifols
Baxter International
Cerus Corporation
Opportunities
  • Regulatory Support and Compliance
  • Growing Awareness of Patient Safety
  • Increasing Prevalence of Chronic Diseases

Top Industry Leaders in the Patient Blood Management Market

Patient Blood Management  Key Companies
ย 
Latest Patient Blood Managementย Companies Update:

Masimo (NASDAQ:MASI) Announced a collaboration with the University of Oxford to develop and implement PBM programs in African countries.

Haemonetics Corporation (NYSE:HAE) Launched the next generation of its Cell Saver Elite blood salvage system, offering improved efficiency and patient outcomes.

Haemostypic Technologies (ASX:HAS) Received FDA clearance for its QuikClot Combat Gauze, a hemostatic gauze for fast and effective blood clotting in emergency situations.

Fresenius Kabi (ETR:FRE) Partnered with the World Health Organization (WHO) to provide training and resources on PBM implementation in low- and middle-income countries.

Roche (SWX:ROG) Presented data at the American Society of Hematology meeting demonstrating the effectiveness of its Hemlibra medication in reducing blood transfusions in patients with hemophilia A.

List of Patient Blood Management Key companies in the market
  • Biomรฉrieux SA

  • Bio-Rad Laboratories Inc.

  • Braun Melsungen AG

  • Abbott Laboratories

  • Danaher Corporation

  • Hitachi Ltd

  • Terumo Corporation